The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Shrividya Iyer(Pfizer (United States)), Adam Roughley(Adelphi Group (United Kingdom)), A. Rider(Adelphi Laboratory Center), Gavin Taylor‐Stokes(Adelphi Laboratory Center)

Supportive Care in Cancer

September 11, 2013

10.1007/s00520-013-1959-4

Cited by 225

Abstract

Related Papers

The Measurement of Observer Agreement for Categorical Data

J. Richard Landis, Gary G. Koch|Biometrics|1977|78.3k

The National Comprehensive Cancer Network (NCCN).

Elizabeth H. Wood|Europe PMC (PubMed Central)|2004|2.9k

Non-Small Cell Lung Cancer

|Elsevier eBooks|2016|859

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

Nicholas J. Vogelzang, William Breitbart, David Cella et al.|PubMed|1997|771

Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument

David Cella, Amy E. Bonomi, Stephen Lloyd et al.|Lung Cancer|1995|748